{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:48:36Z","timestamp":1791179316968,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1007\/bf02982079","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T20:59:55Z","timestamp":1227733195000},"page":"375-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Identification, Characterization, and Inhibition of the Platelet ADP Receptors"],"prefix":"10.1007","volume":"74","author":[{"given":"Christian","family":"Gachet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,11,16]]},"reference":[{"key":"BF02982079_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/192531a0","volume":"192","author":"A Gaarder","year":"1961","unstructured":"Gaarder A,Jonsen L, Laland S, Hellem A, Pa O.Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets.Nature. 1961;192:531\u2013532.","journal-title":"Nature"},{"key":"BF02982079_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/194927b0","volume":"194","author":"GVR Born","year":"1962","unstructured":"Born GVR. Aggregation of blood platelets by adenosine diphos phate and its reversal.Nature. 1962;194:27\u201329.","journal-title":"Nature"},{"key":"BF02982079_CR3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0037-1616220","volume":"86","author":"C Gachet","year":"2001","unstructured":"Gachet C. ADP receptors of platelets and their inhibition.Thromb Haemost. 2001;86:222\u2013232.","journal-title":"Thromb Haemost."},{"key":"BF02982079_CR4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0031-6997(24)01373-5","volume":"50","author":"V Ralevic","year":"1998","unstructured":"Ralevic V, Burnstock G. Receptors for purines and pyrimidines.Pharmacol Rev. 1998;50:413\u2013492.","journal-title":"Pharmacol Rev."},{"key":"BF02982079_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/bj2330309","volume":"233","author":"JL Gordon","year":"1986","unstructured":"Gordon JL. Extracellular ATP: effects, sources and fate.Biochem J. 1986;233:309\u2013319.","journal-title":"Biochem J."},{"key":"BF02982079_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0014-5793(93)81397-I","volume":"324","author":"TE Webb","year":"1993","unstructured":"Webb TE, Simon J, Krishek BJ, et al. Cloning and functional expression of a brain G-protein-coupled ATP receptor.FEBS Lett. 1993;324:219\u2013225.","journal-title":"FEBS Lett."},{"key":"BF02982079_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1006\/bbrc.1996.0139","volume":"218","author":"K Ayyanathan","year":"1996","unstructured":"Ayyanathan K, Webbs TE, Sandhu AK, Athwal RS, Barnard EA, Kunapuli SP. Cloning and chromosomal localization of the human P2Y1 purinoceptor.Biochem Biophys Res Commun. 1996;218:783\u2013788.","journal-title":"Biochem Biophys Res Commun."},{"key":"BF02982079_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0378-1119(96)00027-3","volume":"171","author":"C Leon","year":"1996","unstructured":"Leon C, Vial C, Cazenave JP, Gachet C. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor.Gene. 1996;171:295\u2013297.","journal-title":"Gene."},{"key":"BF02982079_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0014-5793(97)00022-7","volume":"403","author":"C Leon","year":"1997","unstructured":"Leon C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.FEBS Lett. 1997;403:26\u201330.","journal-title":"FEBS Lett."},{"key":"BF02982079_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1124\/mol.53.4.727","volume":"53","author":"B Hechler","year":"1998","unstructured":"Hechler B, Vigne P, Leon C, Breittmayer JP, Gachet C, Frelin C. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor.Mol Pharmacol. 1998;53:727\u2013733.","journal-title":"Mol Pharmacol."},{"key":"BF02982079_CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood.V92.1.152.413k27_152_159","volume":"92","author":"B Hechler","year":"1998","unstructured":"Hechler B, Leon C, Vial C, et al.The P2Y1 receptor is necessary for adenosine 5\u2032-diphosphate-induced platelet aggregation.Blood. 1998;92:152\u2013159.","journal-title":"Blood"},{"key":"BF02982079_CR12","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1074\/jbc.273.4.2030","volume":"273","author":"J Jin","year":"1998","unstructured":"Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.J Biol Chem. 1998;273:2030\u20132034.","journal-title":"J Biol Chem."},{"key":"BF02982079_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0014-5793(98)00025-8","volume":"422","author":"P Savi","year":"1998","unstructured":"Savi P, Beauverger P, Labouret C, et al. Role of P2Y1 purinoceptor in ADP-induced platelet activation.FEBS Lett. 1998;422:291\u2013295.","journal-title":"FEBS Lett."},{"key":"BF02982079_CR14","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1074\/jbc.273.4.2024","volume":"273","author":"JL Daniel","year":"1998","unstructured":"Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets.J Biol Chem. 1998;273:2024\u20132029.","journal-title":"J Biol Chem."},{"key":"BF02982079_CR15","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1046\/j.1365-2141.1998.01056.x","volume":"103","author":"B Hechler","year":"1998","unstructured":"Hechler B, Eckly A, Ohlmann P, Cazenave JP, Gachet C.The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.Br J Haematol. 1998;103:858\u2013866.","journal-title":"Br J Haematol."},{"key":"BF02982079_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0014-2999(98)00305-7","volume":"351","author":"J Geiger","year":"1998","unstructured":"Geiger J, Honig-Liedl P, Schanzenbacher P, Walter U. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors.Eur J Pharmacol. 1998;351:235\u2013246.","journal-title":"Eur J Pharmacol."},{"key":"BF02982079_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.bjp.0701827","volume":"124","author":"MS Fagura","year":"1998","unstructured":"Fagura MS, Dainty IA, McKay GD, et al. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP) receptors.Br J Pharmacol. 1998;124:157\u2013164.","journal-title":"Br J Pharmacol."},{"key":"BF02982079_CR18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0037-1614427","volume":"81","author":"HM Jantzen","year":"1999","unstructured":"Jantzen HM, Gousset L, Bhaskar V, et al. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.Thromb Haemost. 1999;81:111\u2013117.","journal-title":"Thromb Haemost."},{"key":"BF02982079_CR19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0037-1614570","volume":"81","author":"C Leon","year":"1999","unstructured":"Leon C, Vial C, Gachet C, et al. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation.Thromb Haemost. 1999;81:775\u2013781.","journal-title":"Thromb Haemost."},{"key":"BF02982079_CR20","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1172\/JCI8399","volume":"104","author":"C Leon","year":"1999","unstructured":"Leon C, Hechler B, Freund M, et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.J Clin Invest. 1999;104:1731\u20131737.","journal-title":"J Clin Invest."},{"key":"BF02982079_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/13522","volume":"5","author":"JE Fabre","year":"1999","unstructured":"Fabre JE, Nguyen M, Latour A, et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.Nat Med. 1999;5:1199\u20131202.","journal-title":"Nat Med."},{"key":"BF02982079_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/35051599","volume":"409","author":"G Hollopeter","year":"2001","unstructured":"Hollopeter G, Jantzen HM, Vincent D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs.Nature. 2001;409:202\u2013207.","journal-title":"Nature."},{"key":"BF02982079_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1172\/JCI110786","volume":"71","author":"DE Macfarlane","year":"1983","unstructured":"Macfarlane DE, Srivastava PC, Mills DC. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.J Clin Invest. 1983;71:420\u2013428.","journal-title":"J Clin Invest."},{"key":"BF02982079_CR24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","volume":"84","author":"P Savi","year":"2000","unstructured":"Savi P, Pereillo JM, Uzabiaga MF, et al. Identification and biological activity of the active metabolite of clopidogrel.Thromb Haemost. 2000;84:891\u2013896.","journal-title":"Thromb Haemost."},{"key":"BF02982079_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1006\/bbrc.2001.4816","volume":"283","author":"P Savi","year":"2001","unstructured":"Savi P, Labouret C, Delesque N, Guette F, Lupker J, Herbert JM. P2Y(12), a new platelet ADP receptor, target of clopidogrel.Biochem Biophys Res Commun. 2001;283:379\u2013383.","journal-title":"Biochem Biophys Res Commun."},{"key":"BF02982079_CR26","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1074\/jbc.M009718200","volume":"276","author":"FL Zhang","year":"2001","unstructured":"Zhang FL, Luo L, Gustafson E, et al. ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999.J Biol Chem. 2001;276:8608\u20138615.","journal-title":"J Biol Chem."},{"key":"BF02982079_CR27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0026-895X(24)12604-1","volume":"60","author":"J Takasaki","year":"2001","unstructured":"Takasaki J, Kamohara M, Saito T, et al. Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor.Mol Pharmacol. 2001;60:432\u2013439.","journal-title":"Mol Pharmacol."},{"key":"BF02982079_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1172\/JCI12242","volume":"107","author":"CJ Foster","year":"2001","unstructured":"Foster CJ, Prosser DM, Agans JM, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.J Clin Invest. 2001;107:1591\u20131598.","journal-title":"J Clin Invest."},{"key":"BF02982079_CR29","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1074\/jbc.271.6.2879","volume":"271","author":"AB MacKenzie","year":"1996","unstructured":"MacKenzie AB, Mahaut-Smith MP, Sage SO. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets.J Biol Chem. 1996;271:2879\u20132881.","journal-title":"J Biol Chem."},{"key":"BF02982079_CR30","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1055\/s-0038-1665441","volume":"78","author":"C Vial","year":"1997","unstructured":"Vial C, Hechler B, Leon C, Cazenave JP, Gachet C. Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines.Thromb Haemost. 1997;78:1500\u20131504.","journal-title":"Thromb Haemost."},{"key":"BF02982079_CR31","doi-asserted-by":"publisher","first-page":"11544","DOI":"10.1074\/jbc.273.19.11544","volume":"273","author":"B Sun","year":"1998","unstructured":"Sun B, Li J, Okahara K, Kambayashi J. P2X1 purinoceptor in human platelets. Molecular cloning and functional characterization after heterologous expression.J Biol Chem. 1998;273:11544\u201311547.","journal-title":"J Biol Chem."},{"key":"BF02982079_CR32","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1182\/blood.V91.9.3172","volume":"91","author":"EE Clifford","year":"1998","unstructured":"Clifford EE, Parker K, Humphreys BD, Kertesy SB, Dubyak GR. The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes.Blood. 1998;91:3172\u20133181.","journal-title":"Blood"},{"key":"BF02982079_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1006\/bbrc.1997.8001","volume":"242","author":"TJ Scase","year":"1998","unstructured":"Scase TJ, Heath MF,Allen JM, Sage SO, Evans RJ. Identification of a P2X1 purinoceptor expressed on human platelets.Biochem Biophys Res Commun. 1998;242:525\u2013528.","journal-title":"Biochem Biophys Res Commun."},{"key":"BF02982079_CR34","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood.V80.11.2787.2787","volume":"80","author":"M Cattaneo","year":"1992","unstructured":"Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.Blood. 1992;80:2787\u20132796.","journal-title":"Blood"},{"key":"BF02982079_CR35","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1172\/JCI117835","volume":"95","author":"P Nurden","year":"1995","unstructured":"Nurden P, Savi P, Heilmann E, et al.An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.J Clin Invest. 1995;95:1612\u20131622.","journal-title":"J Clin Invest."},{"key":"BF02982079_CR36","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V75.5.1081.1081","volume":"75","author":"M Cattaneo","year":"1990","unstructured":"Cattaneo M, Canciani MT, Lecchi A, et al. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.Blood. 1990;75:1081\u20131086.","journal-title":"Blood"},{"key":"BF02982079_CR37","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood.V94.12.4156","volume":"94","author":"C Trumel","year":"1999","unstructured":"Trumel C, Payrastre B, Plantavid M, et al. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase.Blood. 1999;94:4156\u20134165.","journal-title":"Blood"},{"key":"BF02982079_CR38","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1055\/s-0038-1656090","volume":"77","author":"M Cattaneo","year":"1997","unstructured":"Cattaneo M, Lombardi R, Zighetti ML, et al. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.Thromb Haemost. 1997;77:986\u2013990.","journal-title":"Thromb Haemost."},{"key":"BF02982079_CR39","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1161\/01.ATV.20.11.e101","volume":"20","author":"M Cattaneo","year":"2000","unstructured":"Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML. Platelets from a patient heterozygous for the defect of P2(CYC) receptors for ADP have a secretion defect despite normal thromboxane A(2) production and normal granule stores: further evidence that some cases of platelet \u2018primary secretion defect\u2019 are heterozygous for a defect of P2(CYC) receptors.Arterioscler Thromb Vasc Biol. 2000;20:E101-E106.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"BF02982079_CR40","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1182\/blood.V96.6.2134","volume":"96","author":"P Ohlmann","year":"2000","unstructured":"Ohlmann P, Eckly A, Freund M, Cazenave JP, Offermanns S, Gachet C. ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq.Blood. 2000;96:2134\u20132139.","journal-title":"Blood"},{"key":"BF02982079_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0014-5793(01)02824-1","volume":"505","author":"G Kauffenstein","year":"2001","unstructured":"Kauffenstein G, Bergmeier W, Eckly A, et al. The P2Y12 receptor induces platelet aggregation through weak activation of the \u03b1IIb\u03b23 integrin: a phosphoinositide 3-kinase-dependent mechanism.FEBS Lett. 2001;505:281\u2013290.","journal-title":"FEBS Lett."},{"key":"BF02982079_CR42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/47495","volume":"403","author":"K Mulryan","year":"2000","unstructured":"Mulryan K, Gitterman DP, Lewis CJ, et al. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors.Nature. 2000;403:86\u201389.","journal-title":"Nature"},{"key":"BF02982079_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0014-2999(99)00201-0","volume":"372","author":"S Takano","year":"1999","unstructured":"Takano S, Kimura J, Matsuoka I, Ono T. No requirement of P2X1 purinoceptors for platelet aggregation.Eur J Pharmacol. 1999;372:305\u2013309.","journal-title":"Eur J Pharmacol."},{"key":"BF02982079_CR44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-0037-1615684","volume":"85","author":"MG Rolf","year":"2001","unstructured":"Rolf MG, Brearley CA, Mahaut-Smith MP. Platelet shape change evoked by selective activation of P2X1 purinoceptors with \u03b1,\u03b2-methylene ATP.Thromb Haemost. 2001;85:303\u2013308.","journal-title":"Thromb Haemost."},{"key":"BF02982079_CR45","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0022-3565(25)38762-8","volume":"269","author":"P Savi","year":"1994","unstructured":"Savi P, Laplace MC, Maffrand JP, Herbert JM. Binding of [3H]-2-methylthio ADP to rat platelets\u2014effect of clopidogrel and ticlopidine.J Pharmacol Exp Ther. 1994;269:772\u2013777.","journal-title":"J Pharmacol Exp Ther."},{"key":"BF02982079_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0049-3848(94)90186-4","volume":"76","author":"P Savi","year":"1994","unstructured":"Savi P, Laplace MC, Herbert JM. Evidence for the existence of two different ADP-binding sites on rat platelets.Thromb Res. 1994;76:157\u2013169.","journal-title":"Thromb Res."},{"key":"BF02982079_CR47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1365-2141.1995.tb05319.x","volume":"91","author":"C Gachet","year":"1995","unstructured":"Gachet C, Cattaneo M, Ohlmann P, et al. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.Br J Haematol. 1995;91:434\u2013444.","journal-title":"Br J Haematol."},{"key":"BF02982079_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0014-2999(01)00733-6","volume":"412","author":"A Baurand","year":"2001","unstructured":"Baurand A, Raboisson P, Freund M, et al. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.Eur J Pharmacol. 2001;412:213\u2013221.","journal-title":"Eur J Pharmacol."},{"key":"BF02982079_CR49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1055\/s-0038-1650674","volume":"76","author":"DC Mills","year":"1996","unstructured":"Mills DC. ADP receptors on platelets [review].Thromb Haemost. 1996;76:835\u2013856.","journal-title":"Thromb Haemost."},{"key":"BF02982079_CR50","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1124\/mol.54.6.1118","volume":"54","author":"RK Palmer","year":"1998","unstructured":"Palmer RK, Boyer JL, Schachter JB, Nicholas RA, Harden TK. Agonist action of adenosine triphosphates at the human P2Y1 receptor.Mol Pharmacol. 1998;54:1118\u20131123.","journal-title":"Mol Pharmacol."},{"key":"BF02982079_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.bjp.0703517","volume":"131","author":"MP Mahaut-Smith","year":"2000","unstructured":"Mahaut-Smith MP, Ennion SJ, Rolf MG, Evans RJ. ADP is not an agonist at P2X(1) receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets.Br J Pharmacol. 2000;131:108\u2013114.","journal-title":"Br J Pharmacol."},{"key":"BF02982079_CR52","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0026-895X(25)09561-6","volume":"50","author":"JL Boyer","year":"1996","unstructured":"Boyer JL, Romero-Avila T, Schachter JB, Harden TK. Identification of competitive antagonists of the P2Y1 receptor.Mol Pharmacol. 1996;50:1323\u20131329.","journal-title":"Mol Pharmacol."},{"key":"BF02982079_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bjp.0701837","volume":"124","author":"JL Boyer","year":"1998","unstructured":"Boyer JL, Mohanram A, Camaioni E, Jacobson KA, Harden TK. Competitive and selective antagonism of P2Y1 receptors by N6methyl 2\u2032-deoxyadenosine 3\u2032,5\u2032-bisphosphate.Br J Pharmacol. 1998;124:1\u20133.","journal-title":"Br J Pharmacol."},{"key":"BF02982079_CR54","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1161\/01.CIR.103.5.718","volume":"103","author":"C Leon","year":"2001","unstructured":"Leon C, Freund M, Ravanat C, Baurand A, Cazenave JP, Gachet C. Key role of the P2Y(1) receptor in tissue factor-induced thrombindependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.Circulation. 2001;103:718\u2013723.","journal-title":"Circulation"},{"key":"BF02982079_CR55","first-page":"66","volume":"85","author":"RG Humphries","year":"2000","unstructured":"Humphries RG Pharmacology of AR-C69931MX and related compounds: from pharmacological tools to clinical trials.Haematologica. 2000;85:66\u201372.","journal-title":"Haematologica"},{"key":"BF02982079_CR56","first-page":"73","volume":"85","author":"P Savi","year":"2000","unstructured":"Savi P, Herbert JM. Pharmacology of ticlopidine and clopidogrel.Haematologica. 2000;85:73\u201377.","journal-title":"Haematologica"},{"key":"BF02982079_CR57","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/sj.bjp.0703237","volume":"129","author":"A Sugidachi","year":"2000","unstructured":"Sugidachi A, Asai F, Ogawa T, Inoue T, Koike H. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.Br J Pharmacol. 2000;129:1439\u20131446.","journal-title":"Br J Pharmacol."},{"key":"BF02982079_CR58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-0037-1615230","volume":"80","author":"S Levy-Toledano","year":"1998","unstructured":"Levy-Toledano S, Maclouf J, Rosa JP, et al. Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on platelets.Thromb Haemost. 1998;80:463\u2013468.","journal-title":"Thromb Haemost."},{"key":"BF02982079_CR59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0038-1642759","volume":"59","author":"JP Maffrand","year":"1988","unstructured":"Maffrand JP, Bernat A, Delebassee D, Defreyn G, Cazenave JP, Gordon JL. ADP plays a key role in thrombogenesis in rats.Thromb Haemost. 1988;59:225\u2013230.","journal-title":"Thromb Haemost."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02982079\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T17:28:46Z","timestamp":1738690126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02982079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["BF02982079"],"URL":"https:\/\/doi.org\/10.1007\/bf02982079","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}